Testing effectiveness (Phase 2)WithdrawnNCT01981811
What this trial is testing
Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
Who this might be right for
Bipolar 1 DisorderSchizophreniaMental Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc.